BU-NOT-SET

CONTACT US
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Women in leadership
  • Corporate
Eyes
Insight
The state of the oral solid dose development and manufacturing market
  • Drug product
Eyes
Insight
Characterising APIs is Essential for Combo Drug Formulations
  • Drug substance
Eyes
Insight
Outsourcing stability testing
  • Analytical chemistry
Eyes
Insight
Brexit: What’s next for UK pharma?
  • Industry trends
Eyes
Insight
Navigating approval filings choppy international waters
  • Drug substance
Eyes
Insight
Regulatory requirements for drug substances
  • Drug substance
Product check
Insight
Insight
  • Biologics
ReciBioPharm Is Advancing xRNA Production
eBook
  • Drug product
  • Manufacturing
Navigating the complexities of pre-filled syringes for biologics
Insight
  • Drug product
  • Manufacturing
Unlocking the potential of mRNA with robust lyophilisation strategies
Insight
  • Biologics
Advanced Bio Is Advancing AAV Production
Insight
  • Biologics
Advanced is advancing xRNA manufacturing
Insight
  • Drug product
  • Manufacturing
What are the innovations driving the future of sterile drug packaging?
Insight
  • Biologics
Revolutionising gene editing with end-to-end CDMO services
Insight
  • Biologics
Advanced Bio streamlines regulatory compliance
Insight
  • Biologics
Advanced Bio leads nucleic acid innovation